These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29729196)

  • 21. Hepatopulmonary syndrome.
    Koch DG; Fallon MB
    Curr Opin Gastroenterol; 2014 May; 30(3):260-4. PubMed ID: 24686436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNF-α neutralization improves experimental hepatopulmonary syndrome in rats.
    Liu L; Liu N; Zhao Z; Liu J; Feng Y; Jiang H; Han D
    Liver Int; 2012 Jul; 32(6):1018-26. PubMed ID: 22672643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod.
    Baweja S; Kumari A; Negi P; Tomar A; Tripathi DM; Mourya AK; Rastogi A; Subudhi PD; Thangariyal S; Kumar G; Kumar J; Reddy GS; Sood AK; Vashistha C; Sarohi V; Bihari C; Maiwall R; Sarin SK
    J Hepatol; 2023 Jul; 79(1):167-180. PubMed ID: 36996943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tea polyphenols and Levofloxacin alleviate the lung injury of hepatopulmonary syndrome in common bile duct ligation rats through Endotoxin -TNF signaling.
    Zhu J; Qiu J; Chen K; Wang W; Zheng S
    Biomed Pharmacother; 2021 May; 137():111263. PubMed ID: 33516071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury.
    Chen B; Ning JL; Gu JT; Cui J; Yang Y; Wang Z; Zeng J; Yi B; Lu KZ
    Liver Int; 2015 Apr; 35(4):1373-82. PubMed ID: 25113058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of pioglitazone in cirrhotic rats with hepatopulmonary syndrome.
    Cheng TY; Lee WS; Huang HC; Lee FY; Chang CC; Lin HC; Lee SD
    J Chin Med Assoc; 2017 Nov; 80(11):683-689. PubMed ID: 28969989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction.
    Luo B; Abrams GA; Fallon MB
    J Hepatol; 1998 Oct; 29(4):571-8. PubMed ID: 9824266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spleen derived monocytes regulate pulmonary vascular permeability in Hepatopulmonary syndrome through the OSM-FGF/FGFR1 signaling.
    Li L; Li J; Li W; Ma Y; Li S
    Transl Res; 2024 Sep; 271():93-104. PubMed ID: 38797433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CX3CR1 participates in pulmonary angiogenesis in experimental hepatopulmonary syndrome mice through inhibiting AKT/ERK signaling pathway and regulating NO/NOS release.
    Gu HJ; Zuo S; Liu HY; Gu LL; Yang XW; Liao J; Wang QQ; Zhao R; Feng XS; Li HY
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6645-6656. PubMed ID: 31378907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion.
    Thenappan T; Goel A; Marsboom G; Fang YH; Toth PT; Zhang HJ; Kajimoto H; Hong Z; Paul J; Wietholt C; Pogoriler J; Piao L; Rehman J; Archer SL
    Am J Respir Crit Care Med; 2011 Apr; 183(8):1080-91. PubMed ID: 21148721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentoxifylline attenuation of experimental hepatopulmonary syndrome.
    Zhang J; Ling Y; Tang L; Luo B; Chacko BK; Patel RP; Fallon MB
    J Appl Physiol (1985); 2007 Mar; 102(3):949-55. PubMed ID: 17110505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-regulated protein 78 may play a crucial role in promoting the pulmonary microvascular remodeling in a rat model of hepatopulmonary syndrome.
    Zhang H; Lv M; Zhao Z; Jia J; Zhang L; Xiao P; Wang L; Li C; Ji J; Tian X; Li X; Fan Y; Lai L; Liu Y; Li B; Zhang C; Liu M; Guo J; Han D; Ji C
    Gene; 2014 Jul; 545(1):156-62. PubMed ID: 24768185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental models for assessment of pulmonary alterations in hepatopulmonary syndrome].
    Vercelino R; Tieppo J; Forgiarini Junior LA; Dias AS; Marroni CA; Marroni NP
    J Bras Pneumol; 2008 Jul; 34(7):453-60. PubMed ID: 18695789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatopulmonary syndrome: update on recent advances in pathophysiology, investigation, and treatment.
    Grace JA; Angus PW
    J Gastroenterol Hepatol; 2013 Feb; 28(2):213-9. PubMed ID: 23190201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats.
    Chang CC; Chuang CL; Tsai MH; Hsin IF; Hsu SJ; Huang HC; Lee FY; Lee SD
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alveolar type II epithelial cell dysfunction in rat experimental hepatopulmonary syndrome (HPS).
    Yang W; Hu B; Wu W; Batra S; Blackburn MR; Alcorn JL; Fallon MB; Zhang J
    PLoS One; 2014; 9(11):e113451. PubMed ID: 25419825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cirrhosis and hepatopulmonary syndrome.
    Tumgor G
    World J Gastroenterol; 2014 Mar; 20(10):2586-94. PubMed ID: 24627594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome.
    Rabiller A; Nunes H; Lebrec D; Tazi KA; Wartski M; Dulmet E; Libert JM; Mougeot C; Moreau R; Mazmanian M; Humbert M; Hervé P
    Am J Respir Crit Care Med; 2002 Aug; 166(4):514-7. PubMed ID: 12186830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats.
    Chang CC; Lee WS; Hsieh HG; Chuang CL; Huang HC; Lee FY; Lee SD
    PLoS One; 2017; 12(6):e0179809. PubMed ID: 28632747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome.
    Luo B; Liu L; Tang L; Zhang J; Stockard CR; Grizzle WE; Fallon MB
    J Hepatol; 2003 May; 38(5):556-63. PubMed ID: 12713865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.